NHS National Proprietary Pharmaceuticals - Low Molecular Weight Heparins and Fondaparinux Products

Buyer: NHS England

Deadline

Not available — this notice may describe a possible future opportunity.

Region

Not specified

Value

—

Type

Award,contract

SME fit

—

Duration

—

Description

NHS National Proprietary Pharmaceuticals – Low Molecular Weight Heparins and Fondaparinux Products – CM/PHR/25/5732 Period of Framework Agreement: 1 March 2026 to 29 February 2028 with an option or option(s) to extend (at the Authority’s discretion) for a period or periods up to a total of 24 months.

Awarded to

Northumbria Pharma Limited Pfizer Ltd ROVI Biotech Ltd Techdow Pharma England Ltd VENIPHARM LTD

Quick actions

View original notice

Key details

CPV category: —
Procurement method: Open procedure
Published: 18 Dec 2025 11:34
VCSE suitable: —

Reference

OCID: ocds-h6vhtk-05838e
Notice ID: C381280
In our database since: 18 Aug 2026